NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Trecora Resources (NYSE: TREC). Our investigation concerns whether Trecora and certain of its officers and/or directors have violated federal securities laws and/or engaged in other unlawful business practices.
On March 1, 2017, post-market, Trecora announced that the Company’s Audit Committee “concluded that there were errors in the accounting for its equity in earnings from its investment in AMAK in the second and third quarters of 2016.” Further, Trecora advised investors to no longer rely on those quarterly reports and that the Company would restate its financial and operating results for those quarters before filing its annual report for 2016.
If you purchased or otherwise acquired Trecora securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact J. Brandon Walker, Esq. by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Omega Protein, please go to www.bespc.com/trecora. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.